Pharmaceuticals / Drugs

  • Dr. Jiamin Wu
    • Dr. Jiamin Wu's research has been focused on developing needle-free delivery technologies for proteins and peptides to enable pain-free therapies. He is enthusiastic about translating his findings into market-ready solutions. His endeavor in needle-free delivery of skincare products has been supported by Mitacs Business Strategy internship
    • aimed at validating its commercial viability. He is one of the awardees of CRS Young Scientist Travel Grant in 2023.
    • All aspects of anesthesia practice - drugs, effects, monitoring, pharmacology, physiology, respiratory function, cardiac function, operative assessment, anesthesia for different disease processes, airway management, addiction in anesthetists, opioids, fentanyl
    • Gynecologic oncology
    • cancer
    • health care administration
    • clinical trials
    • medical education
  • Kate Smolina
    • Linked health administrative data
    • chronic disease surveillance
    • public health monitoring and reporting
    • health system performance measurement
    • pharmacoepidemiology
    • prescription opioids
    • Drugs in children
    • drugs in pregnancy
    • developmental pharmacology
    • drug metabolism
    • pharmacokinetics
  • Michael R. Law, PhD
    • Pharmaceutical policy
    • prescription drugs
    • health insurance
    • cost of medicines
    • drug costs
    • health policy
    • health care
    • drug advertising
  • David Patrick, MD
    • Antibiotic resistance
    • infectious disease
    • epidemiology
  • Barbara Gobis, BSc(Pharm), RPh, ACPR, MScPhm, PCCP
    • Drug therapy
    • pharmacist scope of practice
    • clinical pharmacist services
    • team-based primary health care
    • primary care networks
    • health care leadership
  • Prof.  Steve Morgan, PhD
    • pharmacare, health care policy, pharmaceutical policy, access to medicines, prescription drug pricing, prescription drug coverage, health care financing, health care spending, Canadian medicare